Cargando…
Fcγ receptor–mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies
New strategies that augment T cell responses are required to broaden the therapeutic arsenal against cancer. CD96, TIGIT, and CD226 are receptors that bind to a communal ligand, CD155, and transduce either inhibitory or activating signals. The function of TIGIT and CD226 is established, whereas the...
Autores principales: | Rogel, Anne, Ibrahim, Fathima M., Thirdborough, Stephen M., Renart-Depontieu, Florence, Birts, Charles N., Buchan, Sarah L., Preville, Xavier, King, Emma V., Al-Shamkhani, Aymen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675451/ https://www.ncbi.nlm.nih.gov/pubmed/35998045 http://dx.doi.org/10.1172/jci.insight.158444 |
Ejemplares similares
-
Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc
por: Dadas, Osman, et al.
Publicado: (2023) -
Distinct Motifs in the Intracellular Domain of Human CD30 Differentially Activate Canonical and Alternative Transcription Factor NF-κB Signaling
por: Buchan, Sarah L., et al.
Publicado: (2012) -
Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques
por: Yan, Xianglei, et al.
Publicado: (2023) -
Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions
por: Qureshi, O. S., et al.
Publicado: (2017) -
Conformation of the Human Immunoglobulin G2 Hinge Imparts Superagonistic Properties to Immunostimulatory Anticancer Antibodies
por: White, Ann L., et al.
Publicado: (2015)